Atlas Trials

A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)

Clinical trial NCT05194839 · TERMINATED

Trial details

NCT number
NCT05194839
Sponsor
Aristea Therapeutics, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Palmoplantar Pustulosis
Start date
2022-01-05
Primary completion
2023-02-13
Enrollment
79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.